Embecta Corp.
NASDAQ:EMBCDrug Manufacturers - Specialty & Generic
+$0.02 today
- Market cap
- $345.06M
- Beta
- 0.81
- P/E (TTM)
- 1.6
- EPS (TTM)
- $1.92
- Dividend yield
- 14.79%
Volume 0.72M
Average 1.95M
EMBC Operating Income
Profit from core operations after operating expenses, before interest and taxes.
Embecta Corp.NASDAQ: EMBC
Operating Income · Q2 FY2026 · quarter ended Mar 2026
Operating income dips below year-ago levels
Q2 FY2026 operating income of $42.9M fell 45.4% year over year, behind the +26.8% change in trailing-twelve-month operating income. Sequentially, it fell 55.8% from the prior quarter. Over 3 fiscal years it compounded at -4.5% a year.
Context
- Operating income amounted to 30.5% of revenue in FY2025, up 15.0 pp from a year earlier.
- Operating income increased in 1 of the last 3 fiscal years.
What to watch
Whether operating income reaches the consensus estimate from 3 analysts of $240.7M (-26.9%) for the fiscal year ending Sep 2026, a slowdown from the +89.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $42.9M-55.8% QoQ
- Last fiscal yearSep 2025
- $329.3M+89.0% YoY
- LTMMar 2026
- $310.5M+26.8% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Income history
USD · from the income statement
- Latest · FY2025
- 329.3M USD
- Year-over-year change
- +89.0%
- 4-year CAGR
- -9.6%
| Period | Period end | Operating Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 329.3M | +89.0% |
| FY2024 | 2024-09-30 | 174.2M | -24.1% |
| FY2023 | 2023-09-30 | 229.6M | -39.3% |
| FY2022 | 2022-09-30 | 378.1M | -23.2% |
| FY2021 | 2021-09-30 | 492M | — |
Operating Income vs competitors
How EMBC compares with its peers on the latest reported figures
- EMBC's LTM Mar 2026 operating income of $310.5M is the highest of the 11 companies compared; the peer median is -$36.09M.
- Its year-over-year change of +26.8% is the 5th highest of 11, against a peer median of -17.9%.
- Operating income amounts to 29.8% of revenue for EMBC, versus a peer median of 46.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $310.5M | +26.8% | -4.5% | 29.8% | |
| LTM Jun 2026 | $96.09M | +129.8% | — | 46.0% | |
| LTM Mar 2026 | $71.2M | +171.3% | — | 10.5% | |
| LTM Mar 2026 | $20.64M | -63.4% | -17.8% | 22.0% | |
| LTM Jun 2026 | -$4.23M | -109.3% | — | 0.9% | |
| LTM Mar 2026 | -$16.29M | +43.2% | — | 0.9% | |
| LTM Mar 2026 | -$55.89M | -35.7% | — | 111.2% | |
| LTM Mar 2026 | -$102.52M | -52.8% | — | 158.9% | |
| LTM Mar 2026 | -$206.61M | -0.0% | — | 5121.8% | |
| LTM Mar 2026 | -$383.5M | -208.0% | — | 46.3% | |
| LTM Mar 2026 | -$461.65M | +28.6% | — | 704.9% | |
| Peer median (excluding EMBC) | -$36.09M | -17.9% | -17.8% | 46.1% | |
Competitors are the stored peer set for EMBC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 1.17B | 1.13B | 1.12B | 1.12B | 1.08B |
| Cost of Revenue | 365M | 354.6M | 370.9M | 394.2M | 400.9M |
| Gross Profit | 800M | 774.9M | 749.9M | 728.9M | 679.5M |
| Gross Margin | 68.7% | 68.6% | 66.9% | 64.9% | 62.9% |
| Research & Development | 63M | 65M | 85.2M | 78.8M | 21.5M |
| Selling, General & Admin | 240.3M | 294.8M | 341.3M | 365.1M | 331.4M |
| Operating Expenses | 308M | 396.8M | 520.3M | 554.7M | 350.2M |
| Depreciation & Amortization | 38M | 31.7M | 32.7M | 42.5M | 51.1M |
| EBITDA | 533M | 334.5M | 245.4M | 199M | 294.7M |
| EBITDA Margin | 45.8% | 29.6% | 21.9% | 17.7% | 27.3% |
| Operating Income | 492M | 378.1M | 229.6M | 174.2M | 329.3M |
| Operating Margin | 42.2% | 33.5% | 20.5% | 15.5% | 30.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 46.2M | 107M | 112.3M | 107.3M |
| Other Income / Expenses | 3M | (121.5M) | (123.9M) | (130M) | (193M) |
| Income Before Tax | 495M | 256.6M | 105.7M | 44.2M | 136.3M |
| Pre-Tax Margin | 42.5% | 22.7% | 9.4% | 3.9% | 12.6% |
| Income Tax Expense | 80M | 33M | 35.3M | (34.1M) | 40.9M |
| Net Income | 414.8M | 223.6M | 70.4M | 78.3M | 95.4M |
| Net Margin | 35.6% | 19.8% | 6.3% | 7.0% | 8.8% |
| EPS (Basic) | 7.31 | 3.92 | 1.23 | 1.36 | 1.64 |
| EPS (Diluted) | 7.31 | 3.89 | 1.22 | 1.34 | 1.62 |
| Weighted Avg Shares | 56.8M | 57.06M | 57.24M | 58.43M | 58.31M |
| Weighted Avg Shares (Diluted) | 56.8M | 57.06M | 57.76M | 58.33M | 58.92M |
Embecta Corp.
NASDAQ:EMBC
Intrinsic Alpha fair value
Locked
Current Price
$6.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.